In killing of cellular targets, natural killer cells employ receptors
that activate them and receptors specific for MHC class I that inhibit
their activation. Progress in understanding the inhibitory receptors
has been rapid, and indications are that they fall into two distinct s
tructural types that appear to utilize the same inhibitory signaling c
ascade; meanwhile, components of the activation cascade are being eluc
idated, permitting us to integrate the pathways involved.